3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Uterine Cervical Neoplasms
1
Solid Neoplasms
1
SCLC
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Metastatic Solid Tumors
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Advanced Solid Tumors
1
Interventions
pembrolizumab
2
Platinum
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Solid Neoplasms
×
Platinum
×
Clear all
NCT04420884
2026-04-08
iintune-1
Takeda
Phase 1/2
Completed
248 enrolled